Aurobindo Pharma Shares Slump 3% as Telangana Facility Gets OAI Classification
Shares of Aurobindo Pharma slumped 3% on 27 May after the company’s Telangana facility received an Official Action Indicated classification from the US Food and Drug...
Tag : US Food and Drug Administration (USFDA)
Lupin’s Facility Gers Six Observations From the USFDA
Lupin Limited announced that its facility in the US received six observations. In its regulatory filing, the company said that the US Food and Drug...
Sun Pharma, Dr Reddy’s, and Aurobindo Pharma Recall Products in the US
Drug manufacturers Sun Pharma, Dr Reddy’s, and Aurobindo Pharma are recalling their products in the United States of America market due to manufacturing issues, according to...
Glenmark Pharmaceuticals Shares Gain 1% on Receiving USFDA Approval
The shares of Glenmark Pharmaceuticals Ltd were trading in the green and 1% higher on 17 May after the company announced receiving final approval from the...
Granules Shares Gain 2% on USFDA Approval
Shares of Granules India Ltd were trading 2% higher on 30 April after it announced receiving approval from the US health authorities to market a...
Zydus Lifesciences Shares Slump 5% as Unit Receives Ten Observations
Shares of Zydus Lifesciences were trading in the red and 5% lower on 24 April after the company’s injectables production plant received ten observations from...
Sun Pharmaceutical Shares Slip 3% as Unit Receives OAI Label from USFDA
Shares of Sun Pharmaceutical Industries Ltd were trading in the red and 3% lower on 12 April after the USFDA issued an ‘official action indicated’...
Alembic Pharmaceuticals Shares Surge 4% on Tentative USFDA Approval
Shares of Alembic Pharmaceuticals Ltd were trading 4% higher on 1 April after the company announced receiving tentative approval from USFDA. In its regulatory filing,...
Aurobindo Pharma Shares Slip 2% as USFDA Raises Procedural and Cleanliness Issues
Shares of Aurobindo Pharma Ltd were trading in red and 2% lower on 15 March after the USFDA raised procedural and cleanliness issues at the...
Torrent Pharma Shares Hit 52-Week High on a Successful USFDA Inspection
Shares of Torrent Pharmaceuticals Ltd hit a 52-week high of Rs 2,742.60 on 6 March after the company announced receiving EIR from the USFDA. In...
